Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
AOD-9604 progressed through six human clinical trials with more than 900 participants but failed to reach statistical significance in its Phase IIb obesity endpoint, and Metabolic Pharmaceuticals terminated development in 2007
Research-verified information Our content references peer-reviewed studies and verified data, ensuring accuracy, integrity, and real-world relevance
Taking a proactive approach can support earlier intervention, more effective treatment options and improved health outcomes
The goal is to provide safe, effective, and accessible treatment
About AOD-9604 AOD-9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone (hGH), specifically corresponding to amino acids 177-191
US$ 21.65
US$ 27.45
US$ 27.90
US$ 27.01
US$ 26.49
